Jacobs Levy Equity Management’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-200,593
| Closed | -$62.6K | – | 1131 |
|
|
2025
Q1 | $62.6K | Sell |
200,593
-91,108
| -31% | -$28.4K | ﹤0.01% | 1055 |
|
|
2024
Q4 | $272K | Buy |
+291,701
| New | +$272K | ﹤0.01% | 880 |
|
|
2024
Q2 | – | Sell |
-62,341
| Closed | -$190K | – | 1022 |
|
|
2024
Q1 | $190K | Hold |
62,341
| – | – | ﹤0.01% | 896 |
|
|
2023
Q4 | $201K | Hold |
62,341
| – | – | ﹤0.01% | 926 |
|
|
2023
Q3 | $239K | Hold |
62,341
| – | – | ﹤0.01% | 904 |
|
|
2023
Q2 | $204K | Sell |
62,341
-1,400
| -2% | -$4.59K | ﹤0.01% | 926 |
|
|
2023
Q1 | $164K | Sell |
63,741
-102,300
| -62% | -$264K | ﹤0.01% | 915 |
|
|
2022
Q4 | $309K | Buy |
+166,041
| New | +$309K | ﹤0.01% | 860 |
|
|
2021
Q2 | – | Sell |
-220,357
| Closed | -$886K | – | 1092 |
|
|
2021
Q1 | $886K | Buy |
220,357
+182,514
| +482% | +$734K | 0.01% | 762 |
|
|
2020
Q4 | $87K | Sell |
37,843
-2,874
| -7% | -$6.61K | ﹤0.01% | 997 |
|
|
2020
Q3 | $234K | Buy |
+40,717
| New | +$234K | ﹤0.01% | 933 |
|
|
2019
Q1 | – | Sell |
-79,094
| Closed | -$191K | – | 1012 |
|
|
2018
Q4 | $191K | Buy |
79,094
+44,984
| +132% | +$109K | ﹤0.01% | 891 |
|
|
2018
Q3 | $193K | Buy |
+34,110
| New | +$193K | ﹤0.01% | 933 |
|